Akesu Sujie

Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Retraction Note: Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms.

Retraction Note: Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms.

Journal: Nature communications

Published: August 06, 2026

Diagnostic value of AHNAK2 immunohistochemical expression in papillary thyroid carcinoma: an immunohistochemical study.

Diagnostic value of AHNAK2 immunohistochemical expression in papillary thyroid carcinoma: an immunohistochemical study.

Journal: Diagnostic pathology

Published: March 25, 2025

Ciliated Muconodular Papillary Tumors of the Lung Harboring STRN::ALK Fusion: Case Report and Review of the Literature.

Ciliated Muconodular Papillary Tumors of the Lung Harboring STRN::ALK Fusion: Case Report and Review of the Literature.

Journal: International journal of surgical pathology

Published: February 07, 2024

Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies.

Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies.

Journal: Nature communications

Published: November 08, 2022

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms.

Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms.

Journal: Nature communications

Published: April 22, 2022

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies.

Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies.

Journal: Nature communications

Published: December 30, 2021

Pathological features of immune-mediated hepatitis due to immune checkpoint inhibitors and anti-angiogenesis targeted therapy

Pathological features of immune-mediated hepatitis due to immune checkpoint inhibitors and anti-angiogenesis targeted therapy

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: April 10, 2020

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.

Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.

Journal: Scientific reports

Published: December 05, 2016

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

Journal: Oncotarget

Published: October 17, 2016

Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.

Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.

Journal: Oncotarget

Published: August 15, 2016

A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions.

A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions.

Journal: Surgical endoscopy

Published: May 11, 2016

Hepatic angiomyolipoma: a clinicopathologic features and prognosis analysis of 182 cases

Hepatic angiomyolipoma: a clinicopathologic features and prognosis analysis of 182 cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: March 10, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026